Institutional Biosafety Committee
The primary responsibility of the Purdue University Institutional Biosafety Committee (IBC) is to review and approve research protocols involving the use of recombinant DNA, synthetic nucleic acids, and/or biohazardous agents that present a risk to humans, animals, and plants, on the West Lafayette Campus, Regional Campuses, or related facilities and operations. The IBC is conducted in accordance with the guidance and requirements of the National Institute of Health (NIH), the Centers for Disease Control (CDC), and Purdue University policies. The IBC convenes as a group as frequently as needed to fulfill its responsibilities.
All PIs have an obligation to be closely familiar with health and safety guidelines applicable to their work and to adhere to them. Purdue’s Radiological and Environmental Management (REM), the Office of Research Administration (ORA) and the Biosafety Officer work to support the IBC in carrying out its responsibilities.